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Summary of human Vibrio cases reported to CDC, 2009  
 
The Cholera and Other Vibrio Illness Surveillance (COVIS) system is a national surveillance system for 
human infections caused by all species of Vibrio; the COVIS database is maintained by the Centers for 
Disease Control and Prevention. Information from COVIS has been used to determine host, food, and 
environmental risk factors for Vibrio infection. 
 
COVIS was initiated by CDC in collaboration with the Food and Drug Administration (FDA), and the Gulf 
Coast states (Alabama, Florida, Louisiana, Mississippi, and Texas) in 1988.  Using the COVIS report form 
(available at http://www.cdc.gov/nationalsurveillance/PDFs/CDC5279_COVISvibriosis.pdf), participating 
health officials report clinical data, including information about underlying illness; detailed history of 
seafood consumption; detailed exposure to a body of water, drippings from raw or live seafood, or 
other contact with marine life in the 7 days before illness onset; and traceback information on 
implicated seafood.  Before 2007, only cholera, which, by definition, is caused by infection with toxigenic 
Vibrio cholerae serogroup O1 or O139 was nationally reportable; in January 2007, infection with other 
species from the family Vibrionaceae (vibriosis) also became nationally reportable.  CDC serotypes all V. 
parahaemolyticus isolates received from state health departments; for V. cholerae, CDC tests for 
serogroups O1, O75, O139, and O141, and determines whether cholera toxin is produced. Although all 
Vibrio infections are nationally notifiable, many cases are likely not recognized because Vibrios are not 
easily identified on routine enteric media.   
 
This report summarizes human Vibrio infections during 2009 reported by states to CDC. Results are 
presented in two categories: 1) toxigenic Vibrio cholerae infections (including both cholera, caused by 
toxigenic V. cholerae O1 or O139, and vibriosis, caused by all other toxigenic V. cholerae serogroups), 
and 2) all other Vibrio infections.  .  Additionally, results are presented by clinical specimen type. The 
Vibrio species may have been isolated from more than one specimen type in a single patient.  It is 
important to note that isolation of Vibrio from an ill patient does not necessarily indicate that the Vibrio 
infection caused the illness.  While many Vibrio species are well-recognized human pathogens, the 
status of some species, including V. damsela, V. furnissii, V. metschnikovii, and V. cincinnatiensis, as 
human enteric or wound pathogens is less clear.   
 
Understanding exposures is essential for control of infections. For toxigenic V. cholerae, exposures are 
summarized first by place of exposure (domestic vs. travel-associated) and then by seafood 
consumption and water exposure. For all other Vibrio infections (Vibrios other than toxigenic V. cholerae 
O1, O139, O141, or O75) exposures are categorized as follows: wound, seafood, and travel. Patients are 
classified as having a wound exposure if they reported sustaining a wound or having a pre-existing 
wound while exposed to marine or estuarine water or during physical contact with marine wildlife in the 
7 days before illness onset.  Patients are classified as having a seafood exposure if they did not report a 
wound but did report consumption of seafood seven days before illness onset.  They are classified as 
having travel exposure if they reported international travel in the seven days before illness onset, 
regardless of wound or seafood exposure.  
National Enteric Disease Surveillance:  
COVIS Annual Summary, 2009 
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Toxigenic Vibrio cholerae  
 
Serogroup O1 & O139 (reportable as cholera) 
In 2009, nine patients with toxigenic V. cholerae serogroup O1 infection and one patient with toxigenic 
V. cholerae serogroup O139 infection were reported. Of the ten patients with toxigenic V. cholerae 
serogroup O1 or O139 infection, six were hospitalized and none died. Infection was travel-associated in 
eight cases (one patient acquired infection while traveling in Pakistan, four while traveling in India, one 
while traveling in the Philippines, one while traveling in Sri Lanka and India, and one while traveling in 
Bangladesh).  Seafood consumption was reported by four of these patients (from the patients who 
traveled in the Philippines, Bangladesh, India, and Sri Lanka/India).  Two patients reported exposure to 
recreational water (patients who traveled in India and Sri Lanka/India); both also reported seafood 
consumption.  Four patients (three who traveled in India and one who traveled in Pakistan) reported no 
exposure to recreational or drinking water and no seafood consumption.   One patient with domestically 
acquired infection reported consumption of shrimp.  The other patient with domestically acquired 
infection reported no recreational water exposure or seafood consumption but did have contact with 
people who had recently traveled from Pakistan. 
 
Serogroup O141 & O75 (reportable as vibriosis) 
In 2009, one patient with toxigenic V. cholerae serogroup O141 infection was reported. This patient 
reported exposure to a freshwater lake in Michigan. The patient was not hospitalized.  
 
In 2009, one patient with toxigenic V. cholerae serogroup O75 infection was reported. This patient was 
not interviewed, so the exposure history is not available.  The patient was hospitalized and survived. 
 
Table 1: Cases of toxigenic V. cholerae, 2009 
State Age Sex Onset Exposure Serogroup 
CA 43 M 8/21/2009 Travel to India O1, Ogawa 
CA 38 M 6/26/2009 Travel to India O1, Ogawa 
IN 13 F 7/2/2009 Travel to Sri Lanka and India O1, Ogawa 
MA 3 F 1/7/2009 Travel to India O1, Ogawa 
NY 2 F 7/8/2009 Travel to Bangladesh O1, Ogawa 
PA 66 M 7/20/2009 Travel to India O1, Inaba 
TN 51 F 4/5/2009 Travel to Philippines O1, Ogawa 
TX 2 M 5/5/2009 Travel to Pakistan O1, Ogawa 
TX 2 F 8/10/2009 Domestic-unknown O1, Ogawa 
NY 62 M 6/30/2009 Domestic-seafood (harvest area unknown) O139 
LA 51 F 4/1/2009 Unknown O75 









In 2009, Vibrio isolates (excluding toxigenic V. cholerae) from 825 patients were reported to COVIS 
(Table 2). Among patients for whom information was available, 36% were hospitalized, and 6% died. The 
most frequently reported species was V. parahaemolyticus, which was isolated from 386 of the 825 
(46%) patients. Of the patients infected with V. parahaemolyticus for whom information was available, 
81 of 359 (23%) were hospitalized, and two of 348(1%) died.  V. alginolyticus was isolated from 129 of 
the 825 (16%) patients; of the patients with information available 15 of 116 (16%) were hospitalized, 
and 2 of 116 (2%) died. V. vulnificus was isolated from 107 of the 825 (13%) patients; of the patients 
with information available, 93 of 103 (90%) were hospitalized, and 32 of 101 (32%) died.  
 
Geographic Location 
Of the 825 cases of vibriosis reported, 251 (30%) were from Gulf Coast states, 217 (26%) from Pacific 
Coast states, 256 (31%) from Atlantic Coast states, and 101 (12%) from non-coastal states (Figure 1). The 
Vibrio species reported most frequently from Gulf Coast states were V. vulnificus (27%), V. 
parahaemolyticus (21%), V. alginolyticus (19%), and non-toxigenic V. cholerae (13%). The Vibrio species 
reported most frequently from non-Gulf Coast states were V. parahaemolyticus (58%), V. alginolyticus 
(14%), V. vulnificus (7%), and non-toxigenic V. cholerae (7%). 
 
Figure 1.  Number of cases of Vibrio infections (excluding toxigenic V. cholerae), by state, 2009 (n=825 in 
42 states).  
 
 
                                                     
1 Vibriosis is defined as infection with a species from the family Vibrionaceae other than toxigenic V. cholerae O1 
or O139.  For this report, vibriosis caused by other toxigenic serogroups of V. cholerae are reported in the section 
on toxigenic V. cholerae infections.  Vibriosis caused by all other Vibrios, including non-toxigenic V. cholerae and 
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Table 2.  Number of vibriosis cases by species, complications, and site of isolation in patients from the United States, 2009.  
  Outcomes*  Specimen Type 
Vibrio Species Patients Hospitalized Deaths Isolates† Stool Blood Wound Other§ 
 N % n/N % n/N % N % n n n n 
V. alginolyticus 129 16 15/116 13 2/116 2 129 15 3 4 71 51 
V. cholerae 
(non-toxigenic) ¶ 
79 10 37/72 51 7/71 10 79 9 39 19 7 14 
V. damsela 3 0 0/3 0 0/3 0 3 0 0 1 2 0 
V. fluvialis 40 5 15/36 42 0/35 0 40 5 28 1 4 7 
V. furnissii 3 0 3/3 100 0/3 0 3 0 0 2 1 0 
V. hollisae 10 1 7/10 70 0/10 0 10 1 10 0 0 0 
V. metschnikovii 2 0 0/1 0 0/1 0 2 0 0 0 1 1 
V. mimicus 20 3 10/20 50 0/19 0 21 3 13 3 2 4 
V. parahaemolyticus 386 47 81/359 23 2/348 1 388 46 314 7 41 26 
V. vulnificus 107 13 93/103 90 32/100 32 114 14 5 75 31 3 
Other** 3 0 1/3 33 0/3 0 3 0 1 0 2 0 
Species not identified 33 4 7/29 24 1/30 3 33 4 8 1 7 16 
Multiple species†† 10 1 5/9 56 1/10 10 22 3 8 4 6 4 
Total 825 100 274/764 36 45/750 6 847 100 430 116 175 126 
* 
Denominators indicate the number of patients with information available. 
† 
The number of isolates is higher than the total number of patients for two reasons.  First, specimens from a single patient may yield isolates of the same Vibrio species from more 
than one specimen source (that is, the isolation of the same Vibrio species from two specimen sources in the same person is counted as 2 isolates).  Second, more than one Vibrio 
species may be isolated from the same patient; each Vibrio species is counted as an isolate. 
§
Includes ear, sputum, urine, other, and missing information. 
¶
Includes non-toxigenic V. cholerae O1 (2 isolates), V. cholerae O139 (1 isolate) and other non-toxigenic V. cholerae non-O1 non-O139  (76 isolates). 
**
V. harveyi and V. diazotrophicus  
††
The following combinations of Vibrio species were each isolated from one patient: V. cholerae non-O1, non-O139, V. parahaemolyticus; V. cholerae non-O1, non-O139, V. mimicus; 
V. alginolyticus, V. metschnikovii; V. fluvialis, V. mimicus; V. alginolyticus V. vulnificus; V. fluvialis, V. parahaemolyticus; V. alginolyticus, V. parahaemolyticus; V. fluvialis V. furnissii; V. 
parahaemolyticus, Vibrio spp - not identified; V. fluvialis, V. parahaemolyticus 
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Specimen Type 
Among the 847 Vibrio isolates2 (excluding toxigenic V. cholerae) reported in 2009, 430 (52%) were from 
stool, 116 (14%) from blood, 175 (21%) from wounds, and 126 from ‘other’ sites. V. parahaemolyticus 
was the species most frequently isolated from stool (314 [73%] of 430 isolates from stool), V. vulnificus 
was the species most frequently isolated from blood (75 [65%] of 116 isolates from blood), and V. 
alginolyticus was the species most frequently isolated from wounds (71 [41%] of 175 isolates from 
wounds). Of those from ‘other sites’, 45 (5%) were from the ear, of which 37 (82%) were V. alginolyticus. 
 
Seasonality 
Cases of vibriosis had a definite peak during the summer months (Figure 2).  Most cases (78%) occurred 
from May to September, with the greatest number in August. 
 
Figure 2.  Number of cases of vibriosis, by month of illness onset or, when onset date not available, 
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Exposures and exposure categories 
Among the 825 vibriosis cases, 250 (30%) were wound-associated, 486 were seafood-associated, and 89
could not be classified.  Among those with a wound exposure, 175 (70%) reported having skin exposed 
to a body of water, 55 (22%) reported handling seafood, and 43 (17%) reported contact with marine 
wildlife.  Among the 236 who reported eating a single seafood item (Table 4), 48% ate oysters (94% of 
whom consumed them raw), 9% ate clams (73% of whom consumed them raw), 10% ate shrimp, and 
19% ate finfish. Among the 825 vibriosis patients, 495 provided travel information; 51 (10%) of these 





 The number of isolates is higher than the total number of patients for two reasons.  First, one patient may have 
the same Vibrio species isolated from more than one specimen type (that is, the isolation of the same Vibrio 
species from two specimen types in the same person is counted as 2 isolates).  Second, more than one Vibrio 
species may be isolated from the same patient; each Vibrio species is counted as an isolate 
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Table 4.  Seafood exposures among patients with foodborne vibriosis who reported eating a single seafood item in the week before illness onset, 
2009  
 Mollusks Crustaceans Other   
 Oysters Clams Mussels Shrimp Lobster Crab Crayfish Other Shellfish* Finfish† Total 
Patients who ate single 
seafood item (%) 
113 (48) 22 (9) 2 (1) 23 (10) 3 (1) 22 (9) 2 (1) 3 (1) 46 (19) 236 
Subset that ate the 
item raw, (%) 
103 (94) 16 (73) 0 (0) 2 (10) 0 (0) 4 (20) 0 (0) 1 (33) 12 (32) 138 (59) 
*
 Other shellfish reported:  Conch 
†
 Finfish reported:  Bonefish (ojo), herring, whitefish, lomu, perch, salmon, tuna, sardines, sea cucumber, tilapia, grouper, mullet, red snapper, flounder, and trout  
 
 
Laboratory   
In 2009, 149 isolates were confirmed at CDC as V. parahaemolyticus; 20 serotypes of V. parahaemolyticus were identified: 34 (23%) were O4:Kuk, 32 
(21%) were O1:Kuk, and 12 (8%) were O3:Kuk, 6 (4%) were of the pandemic clone serotype O3:K6,and 4 (3%) were O1:K56; the remaining 61 were 
one of 15 other serotypes, all 41% of total.   
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